CS226352B1 - Method of preparing l-tronine - Google Patents

Method of preparing l-tronine Download PDF

Info

Publication number
CS226352B1
CS226352B1 CS80477A CS47780A CS226352B1 CS 226352 B1 CS226352 B1 CS 226352B1 CS 80477 A CS80477 A CS 80477A CS 47780 A CS47780 A CS 47780A CS 226352 B1 CS226352 B1 CS 226352B1
Authority
CS
Czechoslovakia
Prior art keywords
type type
cpe
tpeohhha
escherichia coli
nutrient solution
Prior art date
Application number
CS80477A
Other languages
English (en)
Inventor
Vladimir G Debabov
Nelli I Zdanova
Alexandr K Sokolov
Vitalij A Livsic
Jurij I Kozlov
Evgenij M Churges
Nikolaj K Jankovskij
Original Assignee
Vladimir G Debabov
Nelli I Zdanova
Alexandr K Sokolov
Vitalij A Livsic
Jurij I Kozlov
Evgenij M Churges
Nikolaj K Jankovskij
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vladimir G Debabov, Nelli I Zdanova, Alexandr K Sokolov, Vitalij A Livsic, Jurij I Kozlov, Evgenij M Churges, Nikolaj K Jankovskij filed Critical Vladimir G Debabov
Publication of CS226352B1 publication Critical patent/CS226352B1/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/848—Escherichia
    • Y10S435/849—Escherichia coli

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Description

-V-
OmiCAHMS K30EPETEHK3 K JiBTOPCKOMy CBHflETEJIÍCTBy 3aflBjreHO 13.07.79 3aaBKa N? 2781356/28-13
Abtopn H3o6peTeHna: Β.Γ. HeÓaĎoB, H.M. S^aHOBa, A.K. Οοκολοβ, B.A. JlMBniMIÍ, Ώ.Μ. ΚΟ3ΛΟΒ, E.M. Xyprec, H.K. Hhkobckhíí , M.M. rycaTHHep, Α.Φ. ΠΙολμη, B.H._ Αητηποβ, „ T.M. Πθ3£ΗΗΚΟΒΘ 3aaBHTejib: BcecojosHNS HayHHo-HccjieflOBaTejibCKHH HHCTHTyT reae- ΤΗΧΜ Η ΟβΛβΚφϊΗ ΠρΟΜΝΠΝΙβΗΗΝΧ ΜΗΚρΟΟρΓβΗΗΒΜΟΒ \ HA3BAHKE Χ30ΒΡΕΤΕΗΗΉ
Cnocoó nojiyqeHMa h - TpeoHHHa ίΙβοόρβτβΗκθ othocmtch k ΜΗκροδΗΟΛΟΓΗΗβοκοβ npoMNnweHHOCTM,a ημθηηο - κ cnocoóy nojiyqeHMa - TpeoHHHa.
TpeoHMH HBJíHeTcs ne38MeHMMoíí aMKHOKHCJiOTOíí, KOTopaa mwpoKOΠρΜΜβΗΛΘΤΟΗ K8K ΚΟΜΠΟΗβΗΤ paSJIHHHNX ΠΗΤβΤβΛΒΗΝΧ CMeceH MeflH—φϊΗΟΚΟΓΟ ΗΘ3Η ΘΗβΗΗΗ. ΚρΟΜβ ΨΟΓΟ, L —ΤρβΟΗΜΗ ΜΟΧβΤ ČNTb Η3-ΠΟΛΒ3ΟΒΘΗ Β ΚΘΗβΟΤΒβ £OÓaBKH Β niony ΗβΛΟΒβΚΘ Η Β ΚΟρΜ ΚΗΒΟΤ-ηνχ, a τβκχβ xax ρββκτΜΒ λλη $apMan;eBTMXíecKow η χΗΜΗΗβοκο&ΠρΟΜΝΙΠΛβΗΗΟ CTH . Β HacToamee ΒρβΜΗ -τρβΟΗΗΗ nojiyqasoT nyTeM npaMoči φβρΜθπτθ-π;ηη 6es npeípnecTBeHHHKOB c KenonbsoBaHHeM πργθμμοβ npojiyueHTOBTaKHX BHHOB KaK Brevibacterium flavum, Escherichia c»B. , Ce-rinebacterium. aceteacidophilum, Preteus rettgeri, Serratia marcescens, Aerebacter aer©genens, C®rynebacteriusi glutamicum
Ha πητaTejibHux cpe^ax, coflepacanpíx b KanecTBe hctohhhkob yraepo^a rjWK03y, ($pyKTO3y,βρβτβτ, STaHOJi πρκ jjočaBJíeHHM βητθμηηοβ h 3μηηοκηοηοτ hjihhx co^epscamnx cyócTpaTOB, a τθκχθ coAepxamnx hctohhhkh a30TaΗ ΗβΟόΧΟβΗΜΝβ MHHepaJIbHHe COJIH.
MsBecTen cnocoĎ nonyneHMa h -TpeoHHHa c Hcnoab3OBaHHeM MyraH-thhx nrraMMOB Escherichia c©li πρκ rxyÓHHHOM
KyjIbTItBMpOB8HWI4 Ηθ ΠΜΤδΤβΛΒΗΗΧ CpeASX, COflepxamHX γΓΛβΒΟΛΗ,xctohhxkm aaoTa, κ MXHepajtbHue cojim πρκ ΛΟόθΒΛβΗκκ β cpe^yqWCTHX aMMHOKHCJIOT Η ΒΗΤΘΜΗΗΟΒ ΜΛΜ COflepsaqMX WX rHflpOXX3a-. ΤΟΒ όβΛΚΟΒΟΐί MaCCH. ΠρΜ 9T0M ΛΟΟΤΗΓΗγΤ MaKCHMaJIbHHÍÍ ΒΗΧΟΛ 10,4 γ/jx J^-TpeoHHHa β φβρΜθΗΤθπκοΗΗοΙί cpe^e aa 96 nacoB φβρ-ΜβΗΤθρΜΜ /1/. ΠρΗΜβΗΗβΜΗΘ ΜγΤΘΗΤΗΗβ ΙϋΤΘΜΜΗ Escherichia C®li ΧθρβΚ-
Tepwayswcji ποτρβδΗοοτΒ© β xaojreJíííHHe χλχ β Η30ΛβϋπκΗβ κ Μβτκ-0Η0Η6. ' ΜβΒβοτβΗ TaKse cnocoó noxyHeHXH 1/ -TpeoHMHa nyTeM KyjibTX-BHpoBaHMH npoflyijHpyxxiníx ero μηκροοργθηηβμοβ BM^a Escfceri-chia celi Ήβ ΠΜτβτβΛΒΗοϋ cpe^e, co^epxameň hctohhhkh yrjiepofla, aaoTa κ ΗβοδχοβΗΜίιβ MHHepajn>Hne cojih b npxcyTCTBHHβΗτκδκοτκκβ c nocxe^yronniM ΒΗΑβκβΗκβΜ πβκοΓο npcmyKTa /2/. OčmfiM ΗβΑΟοτβτκοΜ οπηοθηηηχ cnocodoB ΗβΒΗοοχκζ ypOBeHh Haxon-ΛβΗΗΗ (,-TpeoHHHa Ha yrjieBo.xax, b hscthocth, Ha rjiBKoae, ko-TOpas ΗΒΛΗΘΤΟΗ ΠρβΛΠΟΠΤΗΤβΛΒΗΗΜ CHpbeM ΠρΗ ΠρΟΗΘΒΟβΟΤΒβ t -Τρβοημηθ λτιη ΜθΑΗΐίΗΗοκκχ nejieft, HeflOCTaTKOM TaKse ηβληθτοη cjihui-ΚΟΜ δΟΛΒΙΠΟβ ΒρβΜΗ φβρΜβΗΤβΙξΗΗ /96-120 HaCOB/ Ha 3ΤΟΜ ΟϊφΒβ .UeJIbD npeftnaraeMOrO Η3θ6ρθΤβΗΗΗ ΗΒΛΗβΤΟΗ ΠΟΒΒΠΠθΗκβ BHXO^anpojtyKTa κ coKpameHwe ΒρβΜβΗκ φβρΜβΗτβρκκ. Ποοτθβλθηηθη πθλβflOCTHraeTGH τθμ, ητο β xanecTBe MXKpoopraHM3MOB, npojjynHpyia-iqHX k-τρβΟΗΜΗ, H3 BHfla Escherichia celi Mcnojib3y- -®t uiTaMM Escherichia celi ΒΗΜΜτβΗβτκκκ M-l, a b KanecT-Be aHTHóHOTHKa - πθηηπηλλμη. Πρκ stom neHHijHjijiHH bhocht b HcxoflHy® nxTaTejibHyio cpejiy bκοΛΜΗβοτΒβ 0,1 - 0,5 γ/λ, a KyxbTHBHpoBaHxe BeflyT Ha πητθτθλβ-Ηοϋ cpe/ζβ, co^epacaqež nxTaTe^bHy© .qoÓaBicy β βη^θ Γκ,ςροκκθβτβSejiKOBoS Maccia, HanpxMep, κηολοτηογο rxflpcxziHaaTa, φβρΜβπτο -xxaaTa κκκ aBTOjrxaaTa ^poatxeS.
KpoMe toto, b npopecce KyjibTHBHpoBaHHH pejiecoo6pa3HO ββοαητβcda^aHcHpoBaHHyr no^nxTKy, co^epacamyio rx©KO3y κ pacTBop hmmjj _axa.
HfraMM BHIBíreHeTXKa M-l οτοδρβΗ b pacceBe nrraMMa VL 334 p YN 7. Ot Hcxo^Horo nrraMMa oh οτληηθθτοη θθμθτηημ Myxo-HflHHM xapaKTepoM ποΒβρχΗοοτκ κολοηηζ, no b ume h ho Jí cnocoÓHOCTbio κ προΛγκφΐΗ TpeoHHHa, Óojiee bucokoS cTaÓMjibHOCTbffi πρκ poc-τβ Ha cpe^ax c nHTaTejrbHHMH .qoóaBKaMH, T.e. cnocoóHocTb®IIOnyjIHUHH KJieTOK COXpaHHTb OCHOBHHe CBOÍÍCTBa /npOAyKpMH Tpeo-HHHa H yCTOÍÍHHBOCTb K neHHIíHJIJIMHy/ nOCJie KyjIbTHBHpOBaHMH Bgthx ycmoBwax. ΠΙτθμμ ^enoHwpoBsh b HeHTpajibHOM My3ee npoMura-JieHHHX MHKp00praHM3M0B ΠρΗ MHCTHTyTe ΒΗΜΠγΘΗΘΤΜΚΘ Η ΜΜββΤperacTpaiíHOHHEtií HOMep ΠΜΠΜΒ - 1856.
ΠΙΤ8ΜΜ BHWMreHeTHKa Μ - 1 coxpaHneT πολθθηηθ ΓβΗβτκΗβοκκβ cBofíCTBa acxojíHoró nrraMMa BHIÍKreHeTWHa VL 334 p YN 7/ CnOCOÓHOCTb K OBepXCHHTeSy TpeoHHHa H yCTOÍÍHMBOCTb Κ ΠΘΗΜ—ijHJíJiHHy, ητο οπρβ£βΛίϊβτοίϊ co^epscaHMeM b KjieTKax βΜΠΛΗμκφιιρο-BSHHOS ΓΜδρΜΛΗΟδ ΠΛ a3MH£H pYK 7 7, HG OTJlMHaeTCíI OT ΗβΓΟ PH£OM ΜΟρφΟΛΟΓΜΉβCKHX ΠρΜ3ΗΒΚ0Β, ĎOJiee BHCOKOÍÍ CTaÓHJIb-HOCTbE COXpaHeHHS ΟΒΟβΜ nOnyjIfllíHH KJieTOK B ΧΟΑβ φβρΜβΗΤΘΙξΗΗHa cpejsax C ΠΗΤΘΤΘΛΒΗΗΜΜ ΛΟδβΒΚΘΜΜ H CnOCOÓHOCTbK) K ÓOJieeBHCOKOMy ypOBHKJ HaKOEUieHHfl Z/“TpeoHHHa. Ββθβθηηθ b Hcxo^Hy© nMTaTeJibHyro cpe^y neHHUHjnrHHa β xojiHHecT—Be 0,1 -0,5 γ/ji πο3βοληθτ ncnojib3OB8Tb oóorameHHyio iiHTaTeJib-HHMH cpeflCTBaMH cpe^y Óea ποτβρκ ochobhhx cbOzSctb πγγημμθ hT6M CaMHM pe3KO HOBHCHTb CKOpOCTb HapamHBaHHfl ÓHOMaCCH B Ha-ηθλβηοη cTajíHH φθρΜθΗτβφϊκ, sa κοτοροίί cjie^yeT npoiíecc ηητθη-οηβηογο ÓHOcKHTeaa ζ -TpeoHHHa. IIpeAaaraeMHS cnocoó npeAycwaTpHBaeT βθλθηηθ nponecca φβρΜθΗ-TaiJHH B OnTHMSJIbHHX yCJIOBHSX 3δ CHeT ΠΟΑίβρΚΘΗΗΗ B XO£e ΠρΟ-Hecca onTHManbHoro οοοτηοςπθηηη yrjiepo.ua h aeoTa η ποοτοηηηογοypoBHH ρΗ, ητο flocTHraeTcs nyTeM Bse^eHMs b xojie φβρΜβΗτβπ,ΗΗcČaJcaHCHpoBaHHoíí πολπμτκη, co^epsameM rjiKKO3y h pacTBop ημμμ-axa. npejyiaraeMEix cnocoó nosBOJineT nojiyHHTb β φβρΜβπτθχ θμκ. 0,5 jiΛ0 30 γ/ji i, -TpeoHHHa aa 40 nacoB φβρΜβΗτβΐίΗΜ Ha nnTaTejib-hoh cpe#e, cojiepxaineH rjuoK03y, MKHepanbHHe cojih h nHTaTejibHHe^OÓaBKM B BH^e rMflpOJIMSaTa, φepMΘH’Γ0JIH3aτa HJIH aBTOJIH3aTaóHOMaccii ^posacež npn jioÓaBJíeHMH b ncxo^Hya nHTao\eJibHyx> epe^yneHMn;HJiJiHHa b KOJinnecTBe 0,1 - 0,5 r/ji. 4 XAPAKTEPMCTMKA ώτθμμθ Escherichia c®li ΒΗΜΜγθηθτηκθ M-l ΠΙτθμμ E. celí ΒΗΗΗγθηθτηκθ M-l, npoflynHpyiomHií L -TpeoHMH,xpaHKTCfl b neHTpajiijHOM My3ee προμβππλθηηηχ MHKpoopraHH3MOBHHCTHTyTa ΒΗΜΡίΓβΗΘΤΜΚΜ Η ΗΜββΤ perMGTpaiíMOHHHíi HOMep B-1856.ΜορφΟ^ΟΓΜΗ, ΓρΘΜΟΤρΜΙξθΤβΛΒΗΚβ CJiaÓO ΠΟΛΒΜΚΗΗβ ΤΟΗΚΜβ ΠΘΛΟΗΚΗc saKpyrjieHHHMM kohiísmm, ρβ3ΜβροΜ 1,5 - 2 mm b jyiHHy.
KyjibTyp ajibHO—žHSHOJiorHHe CKMe πρηβηβκη MHco-neirroHHHií arap. ^epes 24 naca pocra πρκ 37°C oópa3yeTKpyrjiHe, ÓejiOBaTHe, nojiynpo3paHHue Ha οβθτ kojiohhm ^ΗβΜβτροΜ 2-3 MM, nOBepXHOCTB KOJIOHHM ΓΛΘΛΚΘΗ, KpajI ρΟΒΗΗβ HJIH CJieTKaBOJlHKCThie , ςβΗΤρ KOJIOHHM ΠρΗΠΟΛΗΗΤ, CTpyKTypa OJXHOpOAHaa,KOHcMCTeHuHH nacTooCpasHas, jierKO SMyjihrMpyeTCJi.
ArapH3OBaHHag MHHHMajiBHaa cpeja /AjaMca/ c rjiPKoaoii ^íepes 2-e cyTOK pocra npw 37°C oĎpasyeT kojiohhm ΛΗβΜβτροΜ 1-1,5 mm cepoBSTO-ČeJiHe, Kpyrjme, c pobhhmm KpasMH, cjieráaBunyKJiHe, BHyTpeHHHH CTpyKTypa o^HopoflHaa, noBepxHocTb ĎJiec-TsmaH, nepea 4-5 cyroK kojiohmh npnoópeTaroT CHH3HCTyro /MyKo-HflHyK)/ KOHCHCTeHUHlO.
Poct b mhco—πβπτοΗΗΟΜ ĎyjibOHe - nocjie 24 mbcob pocra πρκ 37°CCHjibHoe paBHOMepHoe noMyTHeHHe, HeÓOJibraolS ocaflOK, aanax xa-paKTepHHÍi.
Poct b hhjko^ MMHHMajibHoit cpeae AaaKca - nepe3 jjBoe cyTOKpocra πρκ 37°C aapanHeii cHJibHoe paBHOMepnoe noMyTHeHHe, sa-nax oTcyTCTByeT.
Pocr .no yKOJiy β μηοο-πθπτοηηομ arape - χοροπίΗϋ no BceMy ynojiy.JKejiaTHHy - He pasacnacaeT.
Ha MQjioKe -χοροπικδ ροοτ c KoaryjrHn;Heíí MOJioKa.
Hhjioji - oópaeyeT.
Poct Ha pa3JiMHHHX yrjieBOjiaxi xopoino pacTeT Ha rjiBKoae, JiaKTO-se, MaHHOse, ranaKToae, KCHJioae, $pyKToae, rjiHijepojie η msh—HHTOjie c o6pa3OBaHHeM khcjioth h rasa. yCTQŽHHBO CTb K aHTHgHOTHKaM, ΥΟΤΟΗΗΗΒΟΟΤΒ K neHHIíHJIJIHHy. ΙΠτ8μμ He naToreHBH.
CojepacaHHe iuia3MHjíH. Β τιοΓθρκφΜΗΗβοκοκ cTa^HH pocra κλθτκη coaepsaT okojio 50 κοπηχ πλθθμηαη p YN 7 /moji. Bec 5,7 Mera- ΛΘΛΒτοη/, očecne^MBaromeií ycTOĚ^MBOCTb πιτθμμθ κ nemmujuíMHy η necymefi γθηη τρθοηηηοβογο onepoHa. ΠοτρβδΗοοτΒ b φΒΚτορβχ pocTa. PacTeT Ha MHHHMajihHoií γλεκο3ο-οοΛβΒΟΜ cpe^e /ερθΜΗ reHepanxx 240 mhh./. Poct CTHMyjiHpyeTCHH3.0JieMIíMH0M /βρΘΜΗ ΓβΗθρβΙξΜΗ 60 «ΜΗ/. -Cnocoó ocymecTBJífleTCíí cjiejíyHmKM oópa3OM. IIocéBHoií MaTepnaa KyjrbTypu MHKpoopraHH3Ma Escherichia celiBHJOlreHeTHKa Μ - 1 BHpamHBaBT b τβηβΗΗβ 48 nacoB Ha arapnao-BaHHOÍÍ ΜΗΗΗΜΘΛΒΗΟϋ Ορβ^ξβ, ΟΟΛθρΚβΠίθίί ΠΘΗΗΙίΗΛΛΗΗ /500ΜΚΓ/ίθ/, Η SaTeM CMHBOM $H3H0JI0rH*ieCKMM paCTBOpOM ΚΛβΤΟΚ C ΠΟΒβρΧΗΟΟΤΧKocsKa γοτοβητ KJieTOHHyro cycneH3iw, KOTopyro Mcnojib3yx)T’'λπηsaceBa φβρΜβΗΤθρΗΟΗΗοίί cpejiH.
HananbHas KOHneHTpanHH κπβτοκ b paÓoneM φβρΜβτβρβ Μοχβτ co-3 CTaBJTHTB okojio 2-5.10 kji/μλ. Mcxo^Haa nHTeTejibHaa cpe,qa co-aepacHT rjiBKoey, MHHepajibHHS aaoT, cojiíí, neHaipajiaH a nitTaTejib- t ΗΗβ βΟδβΒΚΜ B BHfle THApOJaMSaTOB ÓeJSKOBOÍÍ MaCCH, HanpHMep, KHC—XOTHHX rHXpOJIH3aTOB, SBT0JIH3βΤΟΒ HJIH φβρΜβΗΤ0^Η33T0B ,ΣζρΟΧΧβϋ.Ha^íanbHííá pH cpe^H ycTaHaBjiHBáx)T Ha ypoBHe 7,0-7,2 η 3βτβΜaBTOMaTHtiecKH noAJíepaciiBaffiT b bthx npejxejiax b xo#e φβρΜβΗτβίξΗΗc noMombK ^aTHHKa pH nyTeM ΒΒβ^βΗΗΗ cČaziaHCHpoBaHHOH πο,ζιπητκη,coflepsaujeS aMMwaK /βοληη3 pacTBop/ h rjiBKOsy. Ββη^γ τογο, titoCHKaceHwe pH cpe^s b xone xyxbTMBHpoBaHHH npo,nyneHTa TpeoHHHaoóycjiOBJíeHO yMeHbmeHHeM KOHneHTpanHH θμμοηηη /asoTa/ b cpe-ae BCjre,a;cTBHe yTOHsapuM ero npo^ypeHTOM, a οοοτηοιπθηηθ Meac^yCKOpOCTHMM yTHJJH3 aiJHK a3OTa H rJIíDKOSH OCTaeTCH ΠρΗΜβρΗΟ noc-TOflHHHM,-το cooTHoraeHHe Meawy KOJixnecTBOM j^aHHHX'κομποηθητοβb nHTaTejibHoS cMecin flOJiacHo οοοτβθτοτβοββτβ cooTHomeHMD weamyCKOpOCTHMH yTMJIXSaHXÍÍ 3THX ΚΟΜΠΟΗβΗΤΟΒ KyjIbTypO# npOflyiieHTQM,hto h flOCTHraeTCfl nyTeM BsefleHus b χο,ςβ φβρΜβΗτβπΗΗ BHmeyxa-saHHoft ΠΟΛΠΗΤΚΚ. TeMnepaTypy nojmepxxBaET Ha ypoBHe 35-37°C.Πβρββ 40-43 naca φβρΜβκτβηΗΗ o6pa3OBaHHHH b nuTaTejibHož cpe^e
Lt -TpeOHHH ΒΗΑβΠΗΒΤ CJieAyXiníIlM ΜβΤΟβΟΜ. BHOMaCCy ΚΛβΤΟΚ npo-syneHTa OT^ejiHiDT hm6o cenapupoBaHneii, λη6ο φΟΒτροΒβΗΗβΜ nO-CHe npe^BapMTeJIbHOÍl OÓpaÓOTKW OKHCblQ K8JIbU;MH /Η3ΒβΟΤΚΟΒΗΜmojiokom/ η ορτοφοοφορΗοϋ khcjiotoíí. C yqeTOM co^epxaHHH τρβο- HJtHa Μ ΚΘΤΜΟΗΟΒ Β ΗΘΤΜΒΗΟΜ paCTBOpe, a ΤΘΚΧβ ΠΜΓΜβΗΤΗΗΧοοβΑΜΗβΗΜδ ηθτμβηηΚ pacTBop nponycKasOT nepes psiA ποολθαοβθ-ΤβΛΒΗΟ ΟΟβΛΜΗβΗΗΗΧ ΚΟΛΟΗΗ C Ο ΟΒβΤΑΑΚ)ΠίΜΜ COpĎeHTOM ΑΛΑ ΠΟΓΛΟ-πιθημα OKpameHHHX coe^HHeHA^ μ ουλβΦοκθτηοηοβ, HanpnMep KY-2-8,JíwaSoH SK-1B sum αρυγμμ θηθλογμζηογο τμπθ β Η-φορωβ jua cop-ČIÍMM ΚΘΤΜΟΗΟΒ Μ ΤρβΟΗΜΗΘ.
CopÓMpOBaHHHÍi ΤρβΟΗΜΗ 9AS0HpyK)T C ΚΟΛΟΗΗΗ C Cyj^OKaTMOHMTOMpacTBopoM aMMHaKa. Φρθκαημ ajiioaTa, coAepaamHe ocHOBHoe koam-ηθοτβο TpeaHMHa, ynapHBamT ποα BaicyyMOM, oxnaxAaroT m κρμοτθλ-JIHSyBT TpeaHMH. ÍUa yCKOpeHHA KpMCTaJIAMSaiíMM ΜΟΧβΤ ÓHTb HCHOJIb30B8H0 flOÓaBJíeHMe CHMpTa. HojryMeHHHii ΤρβΟΗΜΗ ΧρΟΜβΤΟΓρβφΗΠβ c—kh ΟΛΗορο,ζζβΗ m coa©P®ht 97-99 % οοηοβηογο BeiqecTBa. Ληα nojry-ΗβΗΗΑ npenapaTOB ΑΛΑ MeAMAHHCKHX ΙξβΛβδ A0CT8T0HH0 npOBeCTMAOHOAHMTeAbHyX) nepeKpMCTSUAMB aííHSO.
TaKMe npenapaTH MoryT Chtb μοπολβ3οβ8Ηη b cpeflax αλα KyAbTH-BHpOBaHMA ΚΛβΤΟΚ ΤΚΘΗβδ. ΒηΧΟΑ ΠΟ OHHCaHHOMy Bbnne MeTOflyοοοτθβλαθτ 80-95 %. Πρα bhcokoíí κοΗΑβΗτρβίξΗΗ TpeoHMHa b xyjib-TypHoS xHflKOCTM /BHme 18 γ/ji / η οτηοομτθλβηο hm3koh coflep-aaHHM ΠρΜΜβΟΜ ΤρβΟΗΜΗ ΜΟΚβΤ ÍJHTb ΒΗΑβΛβΗ 6es Μ0Π0ΛΒ30ΒΘΗΗΑCTSAHM COpSlíHH Ha ΗΟΗΗΤΘΧ. JUa 3ΤΟΓΟ ΟΟΒβΤΛβΗΗΗδ ρβΟΤΒΟρ KOH—ueHTpHpyroT ynapHBaHHeM b BaxyyMe πρκ ηθβηοοκηχ Te«napa<rypaxm KpMCTajuMSHpyiOT τρβοΗΗΗ íipw ποΗΜΚθΗΗοδ TeMnepaType c AOÓaB—Κθδ HJIM -δβ3 AOÓaBKH 3ΤΗΛΟΒΟΓΟ ΟΠΗρτ'θ. ΠθΟΛβ ΠβρβΚρΗΟΤ8ΚΛΗ3Θ-HMz ncuyzaioT Li -τρβΟΗΜΗ c coAepaaHzeM ochobhoto BenjecTBa 99%i
Cnocoó noACHAeTCA CAeAymíHMH npHMepaiíM. ΠρΜΜβρ 1 ΠοοβΒΗοδ ΜθτβρΗβΛ KyAbTypu npoAypeHTa Escherichia coliBHHHreHeTHKa M-l BHpamHBamr β τβηβΗΜβ 48 nacoB Ha arapzso-BSHHOM ΜΜΗΜΜΘΛΒΗΟδ ΓΛΒΚ03Ο-ΟΟΛβΒΟΗ Cpefle ΟΛβΑΥ^θΓΟ COCTSBa/γ/λ/, ΓΛ»Κ038 - 5,0; KH^CI - 1,0; KH2PO4-1,5j Na2HPO4-3,5;
MgSO4 . 7H20 - 0,1; - . neHMiíiujiHH -500 μκγ/μλ; arap-arap - 20,0; boas αμοτηλληροβθη-HSA, pH 7,0-7,2. ΓλϊΟΚ038 Η ,ΠβΗ MASUJI MH CTepiUM3yK)TCA ΟΤΑβΛΒΗΟm AOÓaBjíAETCA b paeruaBJíeHHyio cpe^y nepeA ee οχλθααθημθμ h no-ceBOM. Bapocray© xyjibTypy ομηβθετ cTepsubHoft ΒΟΑοηροΒΟΑΗοδ — 7 —
BoaoS h nojiyneHHyx) KJieTOHHyro cycneasMK ncnojib3y©T kjix sa-CeBa φβρΜβΗΤβρΟΒ. ΦβρΜδΗΤβρίϊΚΙ ΠρΟΒΟ,ΣζίϊΤ Ha JiaĎOpaTOpHOM φθρΜβΗΤβρθ eMKOCTb® 0,5 ji .
CocTaB hcxo^hoíí mt^TaTejibHoií cpe^n % /no oSbeMy/ 1. /NH4/2SO4 -1,8% 2. K2HPO4 - 0,2% 3. MgSO4 - 0,04% 4. Khcjiothhíí rnflpojiHsaT BBK /b pacneTe na cyxoíí Bec/-0,3% . ... " k 5. ΠβΗΟΓβΟΗΤβΛΒ - 0,1 %
IlHTaTeJibHyK) cpeay CTepiumsyrT coBMecTHo c annapaTOM, nocjienero BBO^flT b cpe^y cTepmiBHym rjiEKO3y - 2 % h neHMipwmH-0,5 γ/ji. 4>epMeHTanjiio Be#yT npw TeMnepaType 35-37° C c ββθγΑβΗΜβΜ cÓajiaHcupoBaHHOM πολπητκη, coflepxame® snímají b kojih-^ecTBe 2,5-2,7 h rjwicoay b KOHneHTpanHM 35 %. IIoAnHTKy bbo^jitno cHtrHa&amp;y aaTninea pH. YpoBeHb pH ycTaHaBJíHBaBT b npe^ejiax7,0-7,2, ο^ΗΒφΗΤΗΟβ hhcjio φβρΜβΗτβρθ 3,5-4,0 r Og/ ji. nac.^Tepea 40 tiaeOB φβρΜβΗτβςιικ b xyjibTypajibHOH shjixocth HaKanjrn-BaeTCH L» -τρβΟΗΗΗ b KOJuraecTBe 30 γ/λ. 3aTpaTH γλ®κο8η Ha0ΜΗτβ3 TpeoHHHa 6 r/r. 5ajiee jJ-TpeoHHH Ba^ejnsOT na xyjrbTypaiibHOÍi acn/ncocTH.
θτογο κ 300 mji KyjrbTypaMbHoíi kh^kocth c KOHneHTpanneS
TpeoHHHa 30 γ/ji irpMóaBjuiBT npn nepeMeniHBaHHH 3 r okhch xajib-IJHa Η 3&amp;ΤΘΜ SOÓaBJIHST θρΤθφθθφθρΗ7® KHCJIOTy AO JXOCTHSeHHHΒβΛΜΗΗΗΗ pH 5,6, pacTBop HarpeBaBT #o 60 °, BH^epsHBaroT 10MHHyT a OTKejisno? ĎHOMaccy Ha φιυΐΒτρβ πολ BaxyyMOM. nojiynen-HKM ΗΗΤΗΒΗΗΗ paCTBOp /οΠΤΗΠβΟΧΘΗ ,ΠΛΟΤΗΟCTb 0,4 ΠρΗ 525 HM B1 cm KraeTe/ nponycxaroT nepea KOJiOHKy c 50 mji οοΒβτΛΗκπξβΜcmojih KA-lp h ocBeTJieHHHH pacTBop /onTHnecxaji anoTHOCTb 0,08/nponycKamT nepea xojioHKy co 150 jo ογΛΒφοκβτκοΗΗΤθ KY-2-8 bΗ - φορΜβ, KOJioHicy npoMHBaxjT 300 mji bo^ee. CopóHpoBaHHíí τρβ-ΟΗΗΗ 9Ji30HpyiDT pacTBopoM 3%—ηογο aMMHaxa, 9JiK>aT ynapHBaxiT no#BaxyyMOM #0 co^epsaHHH cyxnx BemecTB 25%, ^oóaBjíHxiT θτηλοβηζιοππρτ B COOTHOmeHHH 1:1 H OCTaBJIHSOT KpHCTajIJIH3HpOBaTb B ΤβΗβ-ΗΗβ 10 nacoB πρκ TeMnepaType 0° - + 6° C. Κρηοτθλλν b -τρβο- hmhs οτφΗΛίϊΤροΒΗΒευοτ, πρθΜΗΒ3ΐοτ η cymaT. IIojiy^íaiOT 8,1 r /j -TpeoHiraa /βηχολ 90%/. Αηθλμβ μθτοαομ TCX /10 μκγ/noKaaHBaeT OTcyTCTBwe jipyriíx ημηηοκμολοτ· ΠρΗΜβρ 2
HocěBHoň MaTepwajr KyjibTypia npojiyiíeHTa BHMMreHeTHKa M-l πρκ-γοτοβληβτ no npwMepy 1. ΦβρΜθΗτβςη© BeflyT Ha φβρΜβΗΤβρβ eMKOCTbro 0,5 ji. CoeraB hc-χοληο3 nwraTejibHoft cpe^H no npnMepy 1, aa HCKJuoneHHeM toto,hto b KanecTBe πκτβτθΛΒΗοϋ λο6θβκη Hcnojib3yBT φβρΜβΗτοΛΗθβτ BBK b KoasraecTBe 0,5% βμθοτο κηοκοτηογο ΓΟΛρΟΛίίββτβ BBK.YCJIOBHfl φβρΜβΗΤβΙζΗΗ ΚβΚ B ΠρΗΜβρβ 1. %ρθ3 41 ΗβΟ φβρΜβΗΤΗΓζΗΗβ KyjiBTypHoii χηλκοοτη HaKanjiHBaeTCH 1—τρβΟΗΜΗ β KOJinnecTBe29 γ/ji. 4anee 1-τρβθΗΗΗ βηλθληβτ sis KyjibTypHoii khakocth. 4λη 9Τ0Γ0 300 mji ηθτηβηογο pacTBopa Ι-τρβοΗΗΗβ nocjre οτ^β-jieHHH KjieTOK npojxyiieHTa iíeHTpH$yrHpoBaHHeM KyjibTypajibHoSshjikocth /cyxHx BeiqecTB s ηθτηβηομ pacTBope 7,5%, onTwnec-ksh wroTHOCTb 0,6 /525 hm/ ynapuBaroT no# BaxyyMOM πρπ τβΜΠβ-paType 50°C #0 ofitewa 50 mji, aofíaBjííímT TaKoit xe oÓbeM sthjio-βογο cnMjpTa κ KpzcTajumayKT Ι-τρβοΗΖΗ β τβηβκκβ 5 nacoB npwTeMnepaType 0°C. nojiyneHHHe KpHCTajuiBi OT^ejunoT φιωΒτροΒβΗΗθΜ,npOMUBaioT 15 mji stiuioboto οπκρτβ η cymaT. IIojiynamT 6,1 r1-TpeoHHHa, He co^epacaniero no aHaJizsy Μβτο,ςοΜ TCX /10 μκγ/npMMecez .npyrwx aMMHOKMcjioT.
HpKMep 3 IIoceBHoií MaTepzaji KyjibTypu npojiyiieHTa E· coli BHMMreHeTHKa M-l npzroTOBJíJWT no npuMepy 1. 3 ΦβρΜβΗΤβΙξΗΧ) BeAyT Ha φβρΜβΗΤβρβ eMKOCTBJO 2 M . CoCTaB ^CXOJI-hoS nHTaTejibHOíi cpeflH no npzMepy 1, aa McKJUDneHHeM τογο, htob KanecTBe nHTaTejibHoíi \no6aBKH b nHTaTejibHoií cpejie Hcnojib3y-iot aBTOjmeaT jipoacsež b KOJiHnecTBe 0,4%, a co^epsaHMe ηβΗΜίμω-jiHHa 0,2 γ/ji.
Hepea 43 xtaca φβρΜβΗτθΐίΜΗ b KyjibTypajibHOH sch^kocth HaKaruiH-BaeTCJi 18 γ/ji TpeoHHHa. Pacxoji rjiroKOSH no npuMepy 1.
TaKHM oópaaoM κβκ noKa3aHO b θκοπθρμμθητθλβηηχ jsaHHHx,npeflJiaraeMHM cnocoó npeBQcxo^HT no θφφβκτηΒΗοοτη BceHBBecTHNe cnocoČH nojiyneHHH L) -TpeoHHHa Ha yrjiepoflHOMcpe^e. 3a 40-43 naca φβρΜβΗτβηΐίΐί c ηοπολβ3οβ3ημθμHOBoro nrraMMa E. celi BHMWreHeTMKa M-l Ha oóora- ΐηβΗΗΟδ ΠΜΤβΤβΛΒΗΟΐϊ Ορβ,Ζξθ C βθ6 ΘΒΛΘΗΗβΜ neHHIíHJIJIIÍHa B HC“xojíHys) nuTaTeJibHyio cpe^y, cnocoó ποββοληθτ nojjynHTb b xy-jibTypajibHoS 2ch#kocth βθ 30 γ/λ í/-TpeoHHHa óes npHMeceňaMHHOKJÍCJIOT . 10 ΦΟΡΜΖΑΑ Η30ΒΡΞΤΞΗΜΗ 1. CnocoÓ nojiyqeHMa L· -TpeoHXHa πγτβΜ rnyówHHoro Kyjib- TMBWpOBaHHíI npO^yUMpyjOIUMX ero MMKp00praHM3M0B BH£aEscherichia celi Ha πΗτβτβΛΒΗοίί cpene, conepacameii KCToqHHKH yrviepoAa, aeoTa κ HeoÓxoflUMHe MMHepajibHHe cojih B npMCyrCTBHH aHTHÓHOTHKa C ΠΟCJiejíyKmMM ΒΗΑβΛβΗΗβΜ ΙξβΛβΒΟΓΟπρο,π^κτβ, OTjriraammMiícs τθμ, hto, c nejibiD noBtaneHMs Buxona L) -TpeOHHHa H COKpameHMH ΒρβΜβΗΗ φβρΜβΗΤaiJHH B KaneCTBeuHKpoopraHHSMOB, npoíyniípy©mHX I4-τρβοκκΗ, H3 BK^a HCnOJb3yiDT ΠΓΓΒΜΜ BHMWreHeTHKa M-l, a b xanecTBe aHTHÓHOTHKa - πβΗΗίμυυιΚΗ. í 2. Cnocoó ΠΟ Π. 1, ΟΤΛΗΗβΧΗφΙΗΟΗ ΤβΜ, ΗΤΟ ΠβΗΜΗΗΛΛΗΗ BHOCHTb HcxoflHy© nHTaTejjbHyx) cpe^y b κοΛκγβοτεβ 0,1-0,5 γ/ji. 3. CnocoÓ no npwMepy 1, OTjuraa©nfHScH τθμ, 'ήτο KyjibTHBiípoBa-HHe BeayT Ha πκτθτβΛΒΗοίί cpe^e, co,a;epxameži πητ aTejibHy© .noóaBKy B BÍIfle ΓΗΛΡΟΛΗββΤΘ ÓeJtKOBO^ MSCCH, ΗΘΠρΗΜβρ, ΚΗΟΛΟΤΗΟΓΟrn.upo.HMaaTa, φβρΜβΗτοΛΗΒθτβ min θΒτοΛΜββτβ Aposaceft. 4. CnocoÓ no π. 1, OTJiMHasHmíSca τβΜ, ητο b nponecce KyjibTn-ΒΗροΒθΗΗΗ bbqrsv cěajraHCHpoBaHHy© no^nitTKy, co^epsamyx» γλ©-Kosy n pacTBOp aMMHaxa·
HcTOHHHKH ΗΗφΟρΜΒΗΗΗ, πρΗΗΗΤΗβ BO ΒΗΗΜΘΗΗβ ΠρΗ 9Κ0ΠβρΤΗ3β: 1. Πητθητ Αηγληη - 1223470 κλ. C 2 C onyójunc. 1971 r. 2. 3aaBKa ΦΡΓ IE 1792495 κλ. C 12 4 13/06, onyóji. 1972 r. -V' AHHOTAffllfl
UpejmaraeTCH cnocoó nojiyneHMa b-TpeoHKHa c πρΗΜβΗβΗΜθΜηοβογο nrraMMa E. c®Ii BHMHreHeTHxa M-l, κλθτκη κοτοροτο co^epxaT θΜΠΛΗφκηκροΒβΗΗ^το níópHaHyro rmasMH.ny, jíOTJureaicauerocíi οτ κσχο,ζξΗΟΓΟ πιτθμμθ BHHííreHeTMKa VL 334 pYN7pa^OM ΜΟρφΟΛΟrM^eCKMX Jí φΗ3Μ0Λ0ΓΜΗβ0ΚΙίΧ ΠρΗ3Η3Κ0Β μ óojieebhcokoíÍ cnocoóHocTBE nonyasnjuí κ,πβτοκ coxpaHaTB cboh cbojí-cTBa npx KyabTHBHpoBaHHH na oÓorameHHoS πητητθλβηοη cpe^e.3a 40-43 qaca φβρΜβΗΤθηΜκ Ha oÓorameHHOíí ππτβτβΛΒΗοδ cpe^eC ΛΟδβΒΛβΗΜβΜ ΠβΗΜςΐίΛΛΜΗβ B HCXO^Hy© HHTeTeJIbHyX) Cpe^ycnocoó nosBOJiaeT nojrynHTb b KyjibTypaabHoií xh^koctm λο30 τ/χ L> -TpeoHHHa Óee npraíeceS flpyrjrx ημμηοκηοηοτ.

Claims (4)

  1. - ,Ά " PŘEDMĚT VYNÁLEZU
    1. Způsob přípravy L-treoninu submerzní kultivací mikroorganismůrodu Escherichia coli v živném roztoku, který obsahuje uhlík,dusík a potřebné minerální soli v přítomnosti antibiotik a ná-sledujícím oddělením konečného produktu, vyznačující se tím, že - se jako mikroorganismu rodu Escherichia coli,-který produkujeL-treonin, používá kmen Escherichia coli. VNII genetiky M-ICMPMV--1856 a jako antibiotika penicilín.
  2. 2. Způsob podle bodu 1, vyznačující se tím, že se penicilín přivádído výchozího živného roztoku v množství 0,1 až 0,5 g/1.
  3. 3. Způsob podle bodu 1, vyznačující se tím, že se kultivace pro-vádí v živném roztoku, obsahující další část živin ve forměhydrolyzátu bílkovinných látek, například kyselého hydrolyzátu,fermentolyzátu nebo autolyzátu kvasinek.
  4. 4. Způsob podle bodu 1, vyznačující se tím, že se, během kultivacepřidává rovnovážná doplňková směs, obsahující glukózu a amoniak. Uznáno vynálezem na základě výsledků expertizy provedené Státnímvýborem pro vynálezy a objevy SSSR, Moskva, SU
CS80477A 1979-07-13 1980-01-22 Method of preparing l-tronine CS226352B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU792781356A SU943282A1 (ru) 1979-07-13 1979-07-13 Способ получени L-треонина

Publications (1)

Publication Number Publication Date
CS226352B1 true CS226352B1 (en) 1984-03-19

Family

ID=20834297

Family Applications (1)

Application Number Title Priority Date Filing Date
CS80477A CS226352B1 (en) 1979-07-13 1980-01-22 Method of preparing l-tronine

Country Status (8)

Country Link
US (1) US4321325A (cs)
JP (1) JPS5615696A (cs)
CS (1) CS226352B1 (cs)
DD (1) DD148464A3 (cs)
FR (1) FR2461006A1 (cs)
HU (1) HU180566B (cs)
SU (1) SU943282A1 (cs)
YU (1) YU42330B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55156591A (en) * 1979-05-23 1980-12-05 Ajinomoto Co Inc Method for stabilizing property of bacteria containing plasmid
NL8401255A (nl) * 1983-08-05 1985-03-01 Grace W R & Co Werkwijze voor de biologische bereiding van l-aminozuren.
EP0219808B1 (en) * 1985-10-18 1993-12-22 Toray Industries, Inc. Plasmid with wide host range
DE3844959B4 (de) * 1988-10-25 2006-04-27 Ajinomoto Co., Inc. Stamm der Bakterien Escherichia coli BKIIM B-3996, Produzent von L-Threonin
DE3891417T1 (de) * 1988-10-25 1991-01-10 Vnii Genetiki Selektsii Promy Stamm der bakterien escherichia coli bkiim b-3996, produziert von l-threonin
US5976843A (en) 1992-04-22 1999-11-02 Ajinomoto Co., Inc. Bacterial strain of Escherichia coli BKIIM B-3996 as the producer of L-threonine
WO1994011517A1 (en) 1992-11-10 1994-05-26 Ajinomoto Co., Inc. Process for producing l-threonine by fermentation
US5939307A (en) * 1996-07-30 1999-08-17 The Archer-Daniels-Midland Company Strains of Escherichia coli, methods of preparing the same and use thereof in fermentation processes for l-threonine production
RU2148642C1 (ru) * 1998-12-23 2000-05-10 ЗАО "Научно-исследовательский институт АДЖИНОМОТО-Генетика" (ЗАО "АГРИ") Фрагмент днк rhtc, кодирующий синтез белка rhtc, придающего повышенную устойчивость к l-треонину бактериям escherichia coli, и способ получения l-аминокислоты
US7220571B2 (en) * 2000-09-28 2007-05-22 Archer-Daniels-Midland Company Escherichia coli strains which over-produce L-threonine and processes for the production of L-threonine by fermentation
US7368266B2 (en) * 2001-02-13 2008-05-06 Cj Corporation Method for L-threonine production
JP4380305B2 (ja) * 2003-11-21 2009-12-09 味の素株式会社 発酵法によるｌ−アミノ酸の製造法
US7723097B2 (en) * 2005-03-11 2010-05-25 Archer-Daniels-Midland Company Escherichia coli strains that over-produce L-threonine and processes for their production
CN103497979B (zh) * 2005-06-20 2018-09-11 阿彻-丹尼尔斯-米德兰公司 用于改良生产天冬氨酸衍生的氨基酸及化学品的改变的乙醛酸支路
US20070004014A1 (en) * 2005-06-29 2007-01-04 Yuichiro Tsuji Method for producing l-threonine
JP2009153382A (ja) 2006-03-30 2009-07-16 Ajinomoto Co Inc メタノール資化性細菌を用いたカルボン酸の製造法
EP2046949B1 (en) * 2006-07-19 2014-01-15 Ajinomoto Co., Inc. A method for producing an l-amino acid using a bacterium of the enterobacteriaceae family
DE102007051024A1 (de) 2007-03-05 2008-09-11 Evonik Degussa Gmbh Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae
EP1975241A1 (de) 2007-03-29 2008-10-01 Evonik Degussa GmbH Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
DE102007044134A1 (de) 2007-09-15 2009-03-19 Evonik Degussa Gmbh Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
DE102007052270A1 (de) 2007-11-02 2009-05-07 Evonik Degussa Gmbh Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
EP2060636A1 (de) 2007-11-14 2009-05-20 Evonik Degussa GmbH Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
DE102008002309A1 (de) 2008-06-09 2009-12-10 Evonik Degussa Gmbh Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
DE102008044768A1 (de) 2008-08-28 2010-03-04 Evonik Degussa Gmbh Verfahren zur Herstellung von organisch-chemischen Verbindungen unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
EP2267145A1 (de) 2009-06-24 2010-12-29 Evonik Degussa GmbH Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von verbesserten Stämmen der Familie Enterobacteriaceae
EP2762571A1 (de) 2013-01-30 2014-08-06 Evonik Industries AG Mikroorganismus und Verfahren zur fermentativen Herstellung von Aminosäuren
US11053526B2 (en) 2018-08-09 2021-07-06 Evonik Operations Gmbh Process for preparing L amino acids using improved strains of the enterobacteriaceae family
EP3608409A1 (en) 2018-08-09 2020-02-12 Evonik Operations GmbH Process for preparing l amino acids using improved strains of the enterobacteriaceae family

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1176125A (en) * 1967-01-21 1970-01-01 Kyowa Hakko Kogyo Kk Process for Producing L-Threonine.
GB1521032A (en) * 1974-08-08 1978-08-09 Ici Ltd Biological treatment
US4237224A (en) * 1974-11-04 1980-12-02 Board Of Trustees Of The Leland Stanford Jr. University Process for producing biologically functional molecular chimeras
FR2464299A1 (fr) * 1979-08-28 1981-03-06 Inst Genetiki Selektsii Procede de preparation de souches productrices d'acides amines

Also Published As

Publication number Publication date
FR2461006B1 (cs) 1984-03-09
HU180566B (en) 1983-03-28
JPH0120871B2 (cs) 1989-04-18
SU943282A1 (ru) 1982-07-15
JPS5615696A (en) 1981-02-14
FR2461006A1 (fr) 1981-01-30
US4321325A (en) 1982-03-23
YU42330B (en) 1988-08-31
DD148464A3 (de) 1981-05-27
YU77380A (en) 1984-02-29

Similar Documents

Publication Publication Date Title
CS226352B1 (en) Method of preparing l-tronine
AU7495596A (en) Process for the production of morphologically uniform microcapsules and microcapsules that are produced according to this process
AU4813500A (en) Electrochromic media with concentration-enhanced stability, process for the preparation thereof and use in electrochromic devices
WO2002043580A3 (en) Production of microspheres
GB2129810A (en) A process for the preparation of chymosin
AU6154996A (en) Bacterial production of hydrophobic polypeptides
ATE26451T1 (de) Bestaendige und amphotere waessrige dispersionen von synthetischen polymeren.
EP1078884A3 (en) Manufacturing process for quaternary ammonium tannate, a vegetable coagulating/flocculating agent
GR3036634T3 (en) Novel protein polycation conjugates.
KR840008153A (ko) (1h-테트라졸-5-일)-2(1h)-퀴놀리논, 나프티리디논 및 그의 제조방법
IE812234L (en) Concentration of pseudoplastic polysaccharide¹solutions
WO2003032747A1 (fr) Aliments contenant une proteine animale, procede de ramollissement de la proteine animale, et ramollissants utilisables pour ramollir la proteine animale
CA2119057A1 (en) An aqueous liposome system and a method for the preparation of such a liposome system
GB2019410A (en) Immobilized enzyme products
WO2001016359A3 (en) Screen for axon viability
EP0232118A3 (en) Process for the preparation of pyridine-2,3-dicarboxylic acid
CA2012996A1 (en) Method of forming ferrite coatings
EP0103970A3 (en) Amine salts and products containing them
AU558765B2 (en) 1, 2, 3-triazino (4:,5: and 4,5)-thieno (2,3-b) quinolin-4-ones
Kuwana et al. Solubilization of valine-sensitive acetohydroxy acid synthetase from Neurospora mitochondria
AU4299797A (en) Preparation of amidines
AU2003298339A1 (en) Process for the preparation of pregnanes
EP0109818A3 (en) Process for the preparation of penicillin and cephalosporin sulfones
AU2530884A (en) Organic amino salt of an acid, manufacture and use as accelerator
EP0205293A3 (en) Improvements in or relating to methods of producing antibodies